Stocks and Investing
Stocks and Investing
Thu, January 2, 2014
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, December 31, 2013
[ 12:00 AM ] - WOPRAI
Fri, December 27, 2013
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, December 24, 2013
Mon, December 23, 2013
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, December 20, 2013
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, December 19, 2013
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, December 18, 2013
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Maury Raycroft Initiated (ARWR) at Strong Buy and Held Target at $15 on, Dec 18th, 2013
Maury Raycroft of Jefferies, Initiated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Strong Buy and Held Target at $15 on, Dec 18th, 2013.
Maury has made no other calls on ARWR in the last 4 months.
There is 1 other peer that has a rating on ARWR. Out of the 1 peers that are also analyzing ARWR, 0 agree with Maury's Rating of Hold.
This is the rating of the analyst that currently disagrees with Maury
- Edward Tenthoff of "Piper Sandler" Initiated at Buy and Held Target at $12 on, Monday, October 21st, 2013